Back to search
Non-Valvular Atrial Fibrillation (NVAF)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Valvular Atrial Fibrillation (NVAF) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Valvular Atrial Fibrillation (NVAF) trials you may qualify forThe purpose of this study is to provide real-world data useful to address the factors associated to the administration of oral anticoagulants in the elderly pop…
Atrial fibrillation is the most common cardiac arrhythmia. In atrial fibrillation, there is a risk that clots can form in the heart, especially in the left atri…
Background: Atrial fibrillation (AF) is the most common heart rhythm disorder worldwide. Globally, there are 37.5 million people with AF. AF increases the risk…
In the proposed event driven trial, LAA closure devices will be compared in a 1:1 randomization to best medical care in AF patients at high risk of stroke and b…
The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibri…
This study is a retrospective analysis of observational cohorts using data from prospectively collected administrative/claims data to investigate treatment patt…
This study aims to evaluate the endotheliation efficacy of the AnchorMane® Left Atrial Appendage Occluder in non-valvular atrial fibrillation patients at high s…